medigraphic.com
ISSN 0185-3325 (Impreso)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2016, Número 5

<< Anterior Siguiente >>

Salud Mental 2016; 39 (5)


Effects of aerobic exercise training and cranial electrotherapy stimulation on the stress-related hormone, the neurotrophic factor, and mood states in obese middle-aged women: a pilot clinical trial

Su-Youn C, Wi-Young S, Hee-Tae R

Idioma: Ingles.
Referencias bibliográficas: 52
Paginas: 249-256
Archivo PDF: 162.03 Kb.


RESUMEN

Introducción La obesidad, una pandemia mundial, se ha reportado como una posible causa de diversas enfermedades, incluyendo presión arterial alta, diabetes tipo 2 y enfermedades cardiovasculares.
Objetivo El objetivo del presente trabajo fue investigar los efectos de ocho semanas de ejercicio aeróbico regular y la estimulación eléctrica craneal (CES) sobre la hormona relacionada con el estrés, el factor neurotrófico, y los estados de ánimo en mujeres obesas.
Método Los sujetos de este estudio fueron 36 mujeres coreanas de mediana edad con obesidad. Los sujetos fueron divididos aleatoriamente en un grupo control (CON, n = 12), un grupo de ejercicio aeróbico (EX, n = 12) y un grupo de ejercicio y CES aeróbico grupo (EX + CES, n = 12). CES se llevó a cabo con una corriente estimulador de electroterapia craneal micro durante 20 minutos a 100 μA y 0,5 Hz. El ejercicio aeróbico consistía en carrera en cinta rodante durante 40 minutos a 70% de reserva de frecuencia cardíaca de los sujetos (HRR). El estado de ánimo se midió por el perfil de los estados de ánimo (POMS), y la extracción de sangre se realizó para examinar los niveles de las hormonas relacionadas con el estrés (cortisol y la hormona adrenocorticotrópica [ACTH]) y factores neurotróficos (factor neurotrófico derivado del cerebro [BDNF] y factor de crecimiento nervioso [NGF]) antes y después de cada intervención.
Resultados Los niveles de cortisol en plasma, así como las puntuaciones de tensión- ansiedad, depresión, abatimiento, y fatiga-inercia, se redujeron significativamente después de la intervención, en comparación con las mediciones previas a la intervención en los grupos EX y EX + CES (p ‹ .05). Los niveles séricos de BDNF, los niveles de NGF en suero y las puntuaciones Vigor-Actividad aumentaron significativamente después de la intervención, en comparación con las mediciones previas a la intervención en los grupos EX y EX+CES (p ‹ .05). Sin embargo, no hubo diferencia significativa en estos hallazgos entre la EX y los grupos EX + CES (p › .05).
Discusión y conclusión Estos resultados sugieren que el entrenamiento con ejercicio aeróbico podría mejorar el estado de ánimo de las mujeres obesas de mediana edad por medio de una disminución en el cortisol sérico y un aumento en el suero BDNF y NGF


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Villablanca PA, Alegria JR, Mookadam F, Holmes DR Jr et al. Nonexercise activity thermogenesis in obesity management. Mayo Clin Proc 2015;90(4):509-519.

  2. Lopresti AL, Drummond PD. Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment. Prog Neuropsychopharmacol Biol Psychiatry 2013;45:92-99.

  3. Carter FA, Bulik CM, Joyce PR. Direction of weight change in depression. J Affect Disord 1994;30(1):57-60.

  4. Friedman KE, Reichmann SK, Costanzo PR, Musante GJ. Body image partially mediates the relationship between obesity and psychological distress. Obes Res 2002;10(1):33-41.

  5. Hasler G, Pine DS, Gamma A, Milos G et al. The associations between psychopathology and being overweight: a 20-year prospective study. Psychol Med 2004;34(6):1047-1057.

  6. Rapaport MH, Thase ME. Translating the evidence on atypical depression into clinical practice. J Clin Psychiatry 2007;68(4):e11.

  7. Schwartz TL, Nihalani N, Jindal S, Virk S et al. Psychiatric medication induced obesity: a review. Obes Rev 2004;5(3):115-121.

  8. Kivimäki M, Batty GD, Singh-Manoux A, Nabi H et al. Association between common mental disorder and obesity over the adult life course. Br J Psychiatry 2009;195(2):149-155.

  9. Puhl RM, Brownell KD. Psychosocial origins of obesity stigma: toward changing a powerful and pervasive bias. Obes Rev 2003;4(4):213-227.

  10. Keddie AM. Associations between severe obesity and depression: results from the National Health and Nutrition Examination Survey, 2005-2006. Prev Chronic Dis 2011;8(3):A57.

  11. Stachowiak G, Pertyński T, Pertyńska-Marczewska M. Metabolic disorders in menopause. Prz Menopauzalny 2015;14(1):59-64.

  12. Fregni F, Pascual-Leone A. Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS. Nat Clin Pract Neurol 2007;3(7):383-393.

  13. Kirsch DL, Nichols F. Cranial electrotherapy stimulation for treatment of anxiety, depression, and insomnia. Psychiatr Clin North Am 2013;36(1):169-176.

  14. Kirsch DL, Price LR, Nichols F, Marksberry JA et al. Military service member and veteran self reports of efficacy of cranial electrotherapy stimulation for anxiety, posttraumatic stress disorder, insomnia, and depression. US Army Med Dep J 2014;46-54.

  15. Liss S, Liss B. Physiological and therapeutic effects of high frequency electrical pulses. Integr Physiol Behav Sci 1996;31(2):88-95.

  16. Lee SH, Kim WY, Lee CH, Min TJ et al. Effects of cranial electrotherapy stimulation on preoperative anxiety, pain and endocrine response. J Int Med Res 2013;41(6):1788-1795.

  17. Noble EE, Billington CJ, Kotz CM, Wang C. The lighter side of BDNF. Am J Physiol Regul Integr Comp Physiol 2011;300(5):1053-1069.

  18. Schwartz E, Mobbs CV. Hypothalamic BDNF and obesity: found in translation. Nat Med 2012;18(4):496-497.

  19. ACSM. ACSM’s guidelines for exercise testing and prescription. Philadelphia: Lippincott williams & wilkins; 2006.

  20. Kim EJ, Lee SI, Jeong DU, Shin MS et al. Standardization and reliability and validity of the Korean edition of Profile of Mood States (K-POMS). Sleep Med Psychophysiol 2003;10(1):39-51.

  21. McNair DM, Lorr M, Droppleman LF. Profile of mood states manual. San Diego: Educational and Industrial Testing Service; 1992.

  22. Rodriguez-Herreros B, de Grave DD, Lopez-Moliner J, Brenner E et al. Shifted visual feedback of the hand affects reachability judgments in interception. Vision Res 2013;88:30-37.

  23. Schulz A, Vögele C. Interoception and stress. Front Psychol 2015;6:993.

  24. Tichomirowa M, Keck M, Schneider H, Paez-Pereda M et al. Endocrine disturbances in depression. J Endocrinol Invest 2005;28(1):89-99.

  25. Watson S. Mackin P. HPA axis function in mood disorders. Psychiatry 2006;5(5):166-170.

  26. Scott LV, Dinan TG. Vasopressin as a target for antidepressant development: an assessment of the available evidence. J Affect Disord 2002;72(2):113-124.

  27. Board F, Persky H, Hamburg DA. Psychological stress and endocrine functions; blood levels of adrenocortical and thyroid hormones in acutely disturbed patients. Psychosom Med 1956;18(4):324-333.

  28. Deuschle M, Schweiger U, Weber B, Gotthardt U et al. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 1997;82(1):234-238.

  29. Wittert GA, Livesey JH, Espiner EA, Donald RA. Adaptation of the hypothalamopituitary adrenal axis to chronic exercise stress in humans. Med Sci Sports Exerc 1996;28(8):1015-1019.

  30. Fry RW, Morton AR, Keast D. Overtraining in athletes. An update. Sports Med 1991;12(1):32-65.

  31. Traustadóttir T, Bosch PR, Matt KS. The HPA axis response to stress in women: effects of aging and fitness. Psychoneuroendocrinology. 2005;30(4):392-402.

  32. Bartkowska K, Turlejski K, Djavadian RL. Neurotrophins and their receptors in early development of the mammalian nervous system. Acta Neurobiol Exp (Wars) 2010;70(4):454-467.

  33. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008;264(6):527-532.

  34. Wiener CD, de Mello Ferreira S, Pedrotti Moreira F, Bittencourt G et al. Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk. J Affect Disord 2015;184:245- 248.

  35. Araya AV, Orellana X, Godoy D, Soto L et al. Effect of exercise on circulating levels of brain-derived neurotrophic factor (BDNF) in overweight and obese subjects. Horm Metab Res 2013;45(7):541-544.

  36. Lee SS, Yoo JH, Kang S, Woo JH et al. The effects of 12 weeks regular aerobic exercise on brain-derived neurotrophic factor and inflammatory factors in juvenile obesity and type 2 diabetes mellitus. J Phys Ther Sci 2014;26(8):1199-1204.

  37. Woo J, Shin KO, Park SY, Jang KS et al. Effects of exercise and diet change on cognition function and synaptic plasticity in high fat diet induced obese rats. Lipids Health Dis 2013;12:144.

  38. Schulte-Herbrüggen O, Fuchs E, Abumaria N, Ziegler A et al. Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress. J Neurosci Res 2009;87(11):2551-2560.

  39. Danaalamdari L, Kheirouri S, Alizadeh M, Aslani, Z. The association between serum NGF and BDNF levels with obesity in patients with major depression. Nutrition Food Sciences Research 2014;1(1):96.

  40. Lykouras L, Michopoulos J. Anxiety disorders and obesity. Psychiatriki 2011;22(4):307-313.

  41. Sakuragi S, Sugiyama Y. Effects of daily walking on subjective symptoms, mood and autonomic nervous function. J Physiol Anthropol 2006;25(4):281-289.

  42. Petajan JH, Gappmaier E, White AT, Spencer MK et al. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996;39(4):432-441.

  43. Brown SW, Welsh MC, Labbé EE, Vitulli WF et al. Aerobic exercise in the psychological treatment of adolescents. Percept Mot Skills 1992;74(2):555-560.

  44. Archer T, Josefsson T, Lindwall M. Effects of physical exercise on depressive symptoms and biomarkers in depression. CNS Neurol Disord Drug Targets 2014;13(10):1640-1653.

  45. Ströhle A. Physical activity, exercise, depression and anxiety disorders. J Neural Transm (Vienna) 2009;116(6):777-784.

  46. Duman RS. Neurotrophic factors and regulation of mood: role of exercise, diet and metabolism. Neurobiol Aging 2005;1:88-93.

  47. Barclay TH, Barclay RD. A clinical trial of cranial electrotherapy stimulation for anxiety and comorbid depression. J Affect Disord 2014;164:171-177.

  48. Kavirajan HC, Lueck K, Chuang K. Alternating current cranial electrotherapy stimulation (CES) for depression. Cochrane Database Syst Rev 2014;7:CD010521.

  49. Zanardini R, Gazzoli A, Ventriglia M, Perez J et al. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J Affect Disord 2006;91(1):83-86.

  50. Brunoni AR, Machado-Vieira R, Zarate CA Jr, Vieira EL et al. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial. Eur Neuropsychopharmacol 2014;24(7):1144-1151.

  51. Cheeran B, Talelli P, Mori F, Koch G et al. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol 2008;586 (Pt 23):5717-5725.

  52. Ridding MC, Rothwell JC. Is there a future for therapeutic use of transcranial magnetic stimulation? Nat Rev Neurosci 2007;8(7):559-567.




2020     |     www.medigraphic.com